These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

45 related articles for article (PubMed ID: 11965625)

  • 1. Blood pressure drug may prevent diabetes in some people.
    Mayo Clin Health Lett; 2002 Feb; 20(2):4. PubMed ID: 11965625
    [No Abstract]   [Full Text] [Related]  

  • 2. Effect of ramipril on the incidence of diabetes.
    Potter BJ; LeLorier J
    N Engl J Med; 2007 Feb; 356(5):522-3; author reply 523-4. PubMed ID: 17274113
    [No Abstract]   [Full Text] [Related]  

  • 3. Effect of ramipril on the incidence of diabetes.
    Epstein BJ; Cooper-DeHoff RM
    N Engl J Med; 2007 Feb; 356(5):523; author reply 523-4. PubMed ID: 17269176
    [No Abstract]   [Full Text] [Related]  

  • 4. Effect of ramipril on the incidence of diabetes.
    Bangalore S; Messerli FH
    N Engl J Med; 2007 Feb; 356(5):522; author reply 523-4. PubMed ID: 17267916
    [No Abstract]   [Full Text] [Related]  

  • 5. Angiotensin-converting-enzyme inhibitors for impaired glucose tolerance--is there still hope?
    Ingelfinger JR; Solomon CG
    N Engl J Med; 2006 Oct; 355(15):1608-10. PubMed ID: 16980381
    [No Abstract]   [Full Text] [Related]  

  • 6. [Further options with ramipril. Besides cardio- and nephro-protection diabetes prevention, too?].
    MMW Fortschr Med; 2003 Sep; 145(39):47. PubMed ID: 14649075
    [No Abstract]   [Full Text] [Related]  

  • 7. DREAM study and its impact on India.
    Mohan V
    J Assoc Physicians India; 2006 Oct; 54():765-7. PubMed ID: 17214271
    [No Abstract]   [Full Text] [Related]  

  • 8. Ramipril and risk of diabetes.
    Potyk DK
    JAMA; 2002 Jan; 287(2):186; author reply 186-7. PubMed ID: 11779250
    [No Abstract]   [Full Text] [Related]  

  • 9. Long-term effects of ramipril on cardiovascular events and on diabetes: results of the HOPE study extension.
    Bosch J; Lonn E; Pogue J; Arnold JM; Dagenais GR; Yusuf S;
    Circulation; 2005 Aug; 112(9):1339-46. PubMed ID: 16129815
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ramipril and risk of diabetes.
    Shlossberg AH
    JAMA; 2002 Jan; 287(2):186-7. PubMed ID: 11779251
    [No Abstract]   [Full Text] [Related]  

  • 11. Blood pressure drug helps prevent stroke.
    Health News; 2002 May; 8(5):6. PubMed ID: 12132410
    [No Abstract]   [Full Text] [Related]  

  • 12. Reduction of cardiovascular events and microvascular complications in diabetes with ACE inhibitor treatment: HOPE and MICRO-HOPE.
    Gerstein HC
    Diabetes Metab Res Rev; 2002; 18 Suppl 3():S82-5. PubMed ID: 12324991
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The PHARAO study: prevention of hypertension with the angiotensin-converting enzyme inhibitor ramipril in patients with high-normal blood pressure: a prospective, randomized, controlled prevention trial of the German Hypertension League.
    Lüders S; Schrader J; Berger J; Unger T; Zidek W; Böhm M; Middeke M; Motz W; Lübcke C; Gansz A; Brokamp L; Schmieder RE; Trenkwalder P; Haller H; Dominiak P;
    J Hypertens; 2008 Jul; 26(7):1487-96. PubMed ID: 18551027
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of ACE inhibition and AT1-receptor blockade on haemodynamic responses to L-arginine in Type 1 diabetes.
    Komers R; Simkova R; Kazdova L; Ruzickova J; Pelikanova T
    J Renin Angiotensin Aldosterone Syst; 2004 Mar; 5(1):33-8. PubMed ID: 15136972
    [TBL] [Abstract][Full Text] [Related]  

  • 15. More than just hype.
    Shishkov W
    CMAJ; 2003 Jun; 168(13):1647; author reply 1647-8. PubMed ID: 12821617
    [No Abstract]   [Full Text] [Related]  

  • 16. Ramipril: the better angiotensin-converting enzyme inhibitor?
    Gupta R
    Indian Heart J; 2008; 60(3):188-91. PubMed ID: 19240304
    [No Abstract]   [Full Text] [Related]  

  • 17. DREAM and ADOPT: rosiglitazone does what it says on the packet.
    Bilous R
    Diabet Med; 2007 Feb; 24(2):107-9. PubMed ID: 17257270
    [No Abstract]   [Full Text] [Related]  

  • 18. [Prevention of stroke: should high risk patients be treated with angiotensin II converting enzyme inhibitors without regard to their blood pressure levels? ].
    Kes P; Basić-Kes V
    Lijec Vjesn; 2003; 125(1-2):43-5. PubMed ID: 12812028
    [No Abstract]   [Full Text] [Related]  

  • 19. Impact of ramipril on the circadian periodicity of acute myocardial infarction.
    Dagenais GR; Pogue J; Teo KK; Lonn EM; Yusuf S;
    Am J Cardiol; 2006 Sep; 98(6):758-60. PubMed ID: 16950179
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of ramipril and rosiglitazone on cardiovascular and renal outcomes in people with impaired glucose tolerance or impaired fasting glucose: results of the Diabetes REduction Assessment with ramipril and rosiglitazone Medication (DREAM) trial.
    ; Dagenais GR; Gerstein HC; Holman R; Budaj A; Escalante A; Hedner T; Keltai M; Lonn E; McFarlane S; McQueen M; Teo K; Sheridan P; Bosch J; Pogue J; Yusuf S
    Diabetes Care; 2008 May; 31(5):1007-14. PubMed ID: 18268075
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.